Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients: a Single-center Randomised Double-blind Placebo-controlled Exploratory Pilot Clinical Trial

NCT02757443 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.

NCT NCT02757443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02757443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients: a Single-center Randomised Double-blind Placebo-controlled Exploratory Pilot Clinical Trial
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2016
Completion date
May 31, 2021
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgical procedures, heart valve prosthesis implantation